Johnson & Johnson single-shot vaccine 85% effective against severe COVID-19 disease
By SONY SALZMAN, ABC News
(NEW YORK) -- In another promising development for vaccine science, Johnson & Johnson says its vaccine -- a single shot tested against a complex barrage of newly emerged COVID-19 variants -- is 66% effective at preventing symptomatic disease... Read More.
